Amgen Inc (NASDAQ:AMGN) over-valued by 11%
| Website | http://www.amgen.com |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $142,851,358,720 |
| Beta | 0.735245 |
| Average Volume | $2,810,847 |
| Last Dividend | 6.72% |
| Price on Nov 4, 2022 | $277.02 |
| Autochartist™ Valuation | $247.73 |
| Conclusion |
11% over-valued |
| Download Report |
